These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Cardiostimulatory effects of prenalterol, a beta-1 adrenoceptor partial agonist, in vivo and in vitro. Correlation between physiological effects and adenylate cyclase activity. Hedberg A, Carlsson E, Fellenius E, Lundgren B. Naunyn Schmiedebergs Arch Pharmacol; 1982 Feb 08; 318(3):185-91. PubMed ID: 6121296 [Abstract] [Full Text] [Related]
12. Inotropic, chronotropic and dromotropic effects of prenalterol, a new cardiostimulant drug. Moore EN, Aberg G, Spear JF, Hodess AB, Herrmann I, Adler G. Acta Med Scand Suppl; 1982 Feb 08; 659():53-70. PubMed ID: 6958179 [Abstract] [Full Text] [Related]
13. Selectivity of prenalterol for adrenergic receptor subtypes: a potential mechanism of inotropic selectivity. Williams RS. J Cardiovasc Pharmacol; 1983 Feb 08; 5(2):266-71. PubMed ID: 6188901 [Abstract] [Full Text] [Related]
16. Mechanisms of supersensitivity to sympathomimetic amines in the chronically denervated heart of the conscious dog. Vatner DE, Lavallee M, Amano J, Finizola A, Homcy CJ, Vatner SF. Circ Res; 1985 Jul 08; 57(1):55-64. PubMed ID: 2988820 [Abstract] [Full Text] [Related]